Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis.

Grosso, A M

Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis. [electronic resource] - International journal of clinical practice Mar 2011 - 253-63 p. digital

Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review

1742-1241

10.1111/j.1742-1241.2011.02633.x doi


Adult
Aged
Aged, 80 and over
Angiotensin II Type 1 Receptor Blockers--economics
Benzimidazoles--economics
Biphenyl Compounds
Clinical Trials as Topic
Cost-Benefit Analysis
Drug Costs
Female
Heart Failure--drug therapy
Humans
Hypertension--drug therapy
Losartan--economics
Male
Middle Aged
Quality-Adjusted Life Years
Risk Factors
Tetrazoles--economics
Young Adult